Vertically resolved dust optical properties during SAMUM: Tinfou compared to Ouarzazate

Vertical profiles of dust key optical properties are presented from measurements during the Saharan Mineral Dust Experiment (SAMUM) by Raman and depolarization lidar at two ground-based sites and by airborne high spectral resolution lidar. One of the sites, Tinfou, is located close to the border of the Sahara in Southern Morocco and was the main in situ site during SAMUM. The other site was Ouarzazate airport, the main lidar site. From the lidar measurements the spatial distribution of the dust between Tinfou and Ouarzazate was derived for 1 d. The retrieved profiles of backscatter and extinction coefficients and particle depolarization ratios show comparable dust optical properties, a similar vertical structure of the dust layer, and a height of about 4 km asl at both sites. The airborne cross-section of the extinction coefficient at the two sites confirms the low variability in dust properties. Although the general picture of the dust layer was similar, the lidar measurements reveal a higher dust load closer to the dust source. Nevertheless, the observed intensive optical properties were the same. These results indicate that the lidar measurements at two sites close to the dust source are both representative for the SAMUM dust conditions

Learning to Do or Learning While Doing: Reinforcement Learning and Bayesian Optimisation for Online Continuous Tuning

Online tuning of real-world plants is a complex optimisation problem that continues to require manual intervention by experienced human operators. Autonomous tuning is a rapidly expanding field of research, where learning-based methods, such as Reinforcement Learning-trained Optimisation (RLO) and Bayesian optimisation (BO), hold great promise for achieving outstanding plant performance and reducing tuning times. Which algorithm to choose in different scenarios, however, remains an open question. Here we present a comparative study using a routine task in a real particle accelerator as an example, showing that RLO generally outperforms BO, but is not always the best choice. Based on the study's results, we provide a clear set of criteria to guide the choice of algorithm for a given tuning task. These can ease the adoption of learning-based autonomous tuning solutions to the operation of complex real-world plants, ultimately improving the availability and pushing the limits of operability of these facilities, thereby enabling scientific and engineering advancements.Comment: 17 pages, 8 figures, 2 table

Properties of Sediment Trap Catchment Areas in Fram Strait: Results From Lagrangian Modeling and Remote Sensing

Vertical particle fluxes are responsible for the transport of carbon and biogenic material from the surface to the deep ocean, hence understanding these fluxes is of climatic relevance. Sediment traps deployed in Fram Strait within the framework of the Arctic long-term observatory FRAM provide a time-series of vertical particle fluxes in a region of high CO2 uptake. Until now the source area (catchment area) of trapped particles is unclear; however, lateral advection of particles is supposed to play an important role. This study presents a Lagrangian method to backtrack the origin of particles for two Fram Strait moorings equipped with sediment traps in 200 and 2,300 m depth by using the time-dependent velocity field of a high-resolution, eddy-resolving ocean-sea ice model. Our study shows that the extent of the catchment area is larger the deeper the trap and the slower the settling velocity. Chlorophyll-a concentration as well as sea ice coverage of the catchment area are highest in the summer months. The high sea ice coverage in summer compared to winter can possibly be related to a weaker across-strait sea level pressure difference, which allows more sea ice to enter the then well-stratified central Fram Strait where the moorings are located. Furthermore, a backward sea ice tracking approach shows that the origin and age of sea ice drifting through Fram Strait, partly responsible for vertical particle fluxes, varies strongly from year to year, pointing to a high variability in the composition of particles trapped in the moorings

Functional polymorphism in the neuropeptide Y gene promoter (rs16147) is associated with serum leptin levels and waist-hip ratio in women

OBJECTIVE: The neuropeptide-Y (NP-Y) gene is a strong candidate gene in the pathophysiology of obesity-linked behavior, and several single-nucleotide polymorphisms of NP-Y have already been linked to body weight and appetite. However, the results from current studies remain inconclusive. The aim of the present study was to test whether a certain functional genetic variant (SNP rs16147) in the NP-Y promoter gene is associated with serum leptin levels and body fat distribution. METHOD: We genotyped and measured the serum leptin levels of the NP-Y rs16147 polymorphism in 1,097 Caucasian subjects in the context of a population-based, case-control multicenter study. We measured weight, height and waist circumference, from which we then calculated BMI and waist-to-hip ratio (WHR). RESULTS: We found the CT-genotype of the SNP rs16147 to be significantly associated with lower WHRs and higher serum leptin levels in women, compared to homozygote gene carriers. No association between rs16147, WHR and serum leptin levels was found in men. CONCLUSION: Our results provide evidence that the functionally relevant SNP in the NP-Y promoter gene affects body fat distribution and serum leptin levels in women, pointing towards possible behavioral effects of NPY in obesity

The comorbidity profiles and medication issues of patients with multiple system atrophy:a systematic cross-sectional analysis

BACKGROUND: Multiple system atrophy (MSA) is a complex and fatal neurodegenerative movement disorder. Understanding the comorbidities and drug therapy is crucial for MSA patients' safety and management.OBJECTIVES: To investigate the pattern of comorbidities and aspects of drug therapy in MSA patients.METHODS: Cross-sectional data of MSA patients according to Gilman et al. (2008) diagnostic criteria and control patients without neurodegenerative diseases (non-ND) were collected from German, multicenter cohorts. The prevalence of comorbidities according to WHO ICD-10 classification and drugs administered according to WHO ATC system were analyzed. Potential drug-drug interactions were identified using AiDKlinik®.RESULTS: The analysis included 254 MSA and 363 age- and sex-matched non-ND control patients. MSA patients exhibited a significantly higher burden of comorbidities, in particular diseases of the genitourinary system. Also, more medications were prescribed MSA patients, resulting in a higher prevalence of polypharmacy. Importantly, the risk of potential drug-drug interactions, including severe interactions and contraindicated combinations, was elevated in MSA patients. When comparing MSA-P and MSA-C subtypes, MSA-P patients suffered more frequently from diseases of the genitourinary system and diseases of the musculoskeletal system and connective tissue.CONCLUSIONS: MSA patients face a substantial burden of comorbidities, notably in the genitourinary system. This, coupled with increased polypharmacy and potential drug interactions, highlights the complexity of managing MSA patients. Clinicians should carefully consider these factors when devising treatment strategies for MSA patients.</p

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

BackgroundProgressive supranuclear palsy (PSP) is usually diagnosed in elderly. Currently, little is known about comorbidities and the co-medication in these patients.ObjectivesTo explore the pattern of comorbidities and co-medication in PSP patients according to the known different phenotypes and in comparison with patients without neurodegenerative disease.MethodsCross-sectional data of PSP and patients without neurodegenerative diseases (non-ND) were collected from three German multicenter observational studies (DescribePSP, ProPSP and DANCER). The prevalence of comorbidities according to WHO ICD-10 classification and the prevalence of drugs administered according to WHO ATC system were analyzed. Potential drug-drug interactions were evaluated using AiDKlinik (R).ResultsIn total, 335 PSP and 275 non-ND patients were included in this analysis. The prevalence of diseases of the circulatory and the nervous system was higher in PSP at first level of ICD-10. Dorsopathies, diabetes mellitus, other nutritional deficiencies and polyneuropathies were more frequent in PSP at second level of ICD-10. In particular, the summed prevalence of cardiovascular and cerebrovascular diseases was higher in PSP patients. More drugs were administered in the PSP group leading to a greater percentage of patients with polypharmacy. Accordingly, the prevalence of potential drug-drug interactions was higher in PSP patients, especially severe and moderate interactions.ConclusionsPSP patients possess a characteristic profile of comorbidities, particularly diabetes and cardiovascular diseases. The eminent burden of comorbidities and resulting polypharmacy should be carefully considered when treating PSP patients

Arctic Observatory FRAM

FRAM (FRontiers in Arctic Marine Monitoring) targets a modern vision of integrated underwater infrastructure. FRAM enhances sustainable knowledge for science, society and maritime economy as it enables truly year round observations from surface to depth in the remote and harsh arctic sea. Cutting edge technologies are being (further) developed and used to record essential ocean variables to improve our understanding of the Arctic and it’s ongoing processes. Data will be made freely available to the public via the AWI data portal